AGIO vs. PFE
Compare and contrast key facts about Agios Pharmaceuticals, Inc. (AGIO) and Pfizer Inc. (PFE).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: AGIO or PFE.
Key characteristics
| AGIO | PFE | |
|---|---|---|
| YTD Return | 110.28% | 3.29% |
| 1Y Return | 129.67% | -1.35% |
| 3Y Return (Ann) | -0.12% | -9.58% |
| 5Y Return (Ann) | 9.29% | -0.73% |
| 10Y Return (Ann) | -5.69% | 3.99% |
| Sharpe Ratio | 2.56 | 0.00 |
| Sortino Ratio | 3.93 | 0.18 |
| Omega Ratio | 1.43 | 1.02 |
| Calmar Ratio | 1.58 | 0.00 |
| Martin Ratio | 14.63 | 0.01 |
| Ulcer Index | 9.19% | 8.20% |
| Daily Std Dev | 52.46% | 24.19% |
| Max Drawdown | -87.36% | -69.25% |
| Current Drawdown | -65.31% | -47.60% |
Fundamentals
| AGIO | PFE | |
|---|---|---|
| Market Cap | $2.66B | $163.54B |
| EPS | -$6.61 | -$0.45 |
| PEG Ratio | 0.00 | 0.22 |
| Total Revenue (TTM) | $23.91M | $42.41B |
| Gross Profit (TTM) | $16.86M | $24.40B |
| EBITDA (TTM) | -$299.82M | $9.98B |
Correlation
The correlation between AGIO and PFE is 0.25, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
AGIO vs. PFE - Performance Comparison
In the year-to-date period, AGIO achieves a 110.28% return, which is significantly higher than PFE's 3.29% return. Over the past 10 years, AGIO has underperformed PFE with an annualized return of -5.69%, while PFE has yielded a comparatively higher 3.99% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
AGIO vs. PFE - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Agios Pharmaceuticals, Inc. (AGIO) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
AGIO vs. PFE - Dividend Comparison
AGIO has not paid dividends to shareholders, while PFE's dividend yield for the trailing twelve months is around 5.87%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AGIO Agios Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
PFE Pfizer Inc. | 5.87% | 5.70% | 3.12% | 2.64% | 3.92% | 3.68% | 3.12% | 3.54% | 3.70% | 3.48% | 3.34% | 3.14% |
Drawdowns
AGIO vs. PFE - Drawdown Comparison
The maximum AGIO drawdown since its inception was -87.36%, which is greater than PFE's maximum drawdown of -69.25%. Use the drawdown chart below to compare losses from any high point for AGIO and PFE. For additional features, visit the drawdowns tool.
Volatility
AGIO vs. PFE - Volatility Comparison
Agios Pharmaceuticals, Inc. (AGIO) has a higher volatility of 10.37% compared to Pfizer Inc. (PFE) at 6.26%. This indicates that AGIO's price experiences larger fluctuations and is considered to be riskier than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
AGIO vs. PFE - Financials Comparison
This section allows you to compare key financial metrics between Agios Pharmaceuticals, Inc. and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities